XML 28 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
Valuation
6 Months Ended
Jun. 30, 2017
Fair Value Disclosures [Abstract]  
Valuation
Valuation
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at June 30, 2017:
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
(In thousands)
Cash equivalents
 
$
20,000

 
$

 
$

 
$
20,000

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
1,008,975

 
$
4,896

 
$
1,013,871

U.S. Treasury securities
 

 
22,165

 

 
22,165

Private label residential mortgage-backed securities
 

 
55,427

 
79,123

 
134,550

Private label commercial mortgage-backed securities
 

 
20,036

 
13,809

 
33,845

Commercial mortgage loans
 

 

 
65,896

 
65,896

Residential mortgage loans
 

 

 
136,097

 
136,097

Collateralized loan obligations
 

 
79,614

 
42,536

 
122,150

Consumer loans and asset-backed securities backed by consumer loans
 

 

 
108,671

 
108,671

Corporate debt
 

 
74,049

 
20,535

 
94,584

Real estate owned
 

 

 
24,977

 
24,977

Corporate equity investments
 
1,625

 

 
35,698

 
37,323

Total investments, at fair value
 
1,625

 
1,260,266

 
532,238

 
1,794,129

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 

 

 
5,107

 
5,107

Credit default swaps on corporate bond indices
 

 
880

 

 
880

Credit default swaps on corporate bonds
 

 
6,507

 

 
6,507

Credit default swaps on asset-backed indices
 

 
7,426

 

 
7,426

Interest rate swaps
 

 
6,611

 

 
6,611

Options
 
25

 
2

 

 
27

Futures
 
44

 

 

 
44

Total financial derivatives–assets, at fair value
 
69

 
21,426

 
5,107

 
26,602

Repurchase agreements
 

 
266,659

 

 
266,659

Total investments and financial derivatives–assets, at fair value and repurchase agreements
 
$
1,694

 
$
1,548,351

 
$
537,345

 
$
2,087,390

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(450,055
)
 
$

 
$
(450,055
)
Government debt
 

 
(172,480
)
 

 
(172,480
)
Corporate debt
 

 
(61,267
)
 

 
(61,267
)
Common stock
 
(3,432
)
 

 

 
(3,432
)
Total investments sold short, at fair value
 
(3,432
)
 
(683,802
)
 

 
(687,234
)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 

 
(7,361
)
 

 
(7,361
)
Credit default swaps on corporate bonds
 

 
(11,885
)
 

 
(11,885
)
Credit default swaps on asset-backed indices
 

 
(1,770
)
 

 
(1,770
)
Credit default swaps on asset-backed securities
 

 

 
(207
)
 
(207
)
 
 
 
 
 
 
 
 
 
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
(continued)
 
(In thousands)
Interest rate swaps
 
$

 
$
(4,413
)
 
$

 
$
(4,413
)
Total return swaps
 

 
(1
)
 

 
(1
)
Futures
 
(47
)
 

 

 
(47
)
Forwards
 

 
(1,319
)
 

 
(1,319
)
Total financial derivatives–liabilities, at fair value
 
(47
)
 
(26,749
)
 
(207
)
 
(27,003
)
Total investments sold short and financial derivatives–liabilities, at fair value
 
$
(3,479
)
 
$
(710,551
)
 
$
(207
)
 
$
(714,237
)

The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of June 30, 2017:
 
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities
 
$
28,050

 
Market Quotes
 
Non Binding Third-Party Valuation
 
$
45.12

 
$
188.00

 
$
86.92

Collateralized loan obligations
 
39,195

 
Market Quotes
 
Non Binding Third-Party Valuation
 
37.54

 
438.51

 
112.64

Corporate debt and non-exchange traded corporate equity
 
13,506

 
Market Quotes
 
Non Binding Third-Party Valuation
 
1.38

 
99.50

 
82.85

Private label commercial mortgage-backed securities
 
7,992

 
Market Quotes
 
Non Binding Third-Party Valuation
 
5.38

 
41.43

 
23.46

Agency interest only residential mortgage-backed securities
 
1,644

 
Market Quotes
 
Non Binding Third-Party Valuation
 
16.52

 
19.74

 
18.12

Private label residential mortgage-backed securities
 
51,073

 
Discounted Cash Flows
 
Yield
 
2.8
%
 
39.3
%
 
10.0
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
83.3
%
 
11.0
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.5
%
 
54.6
%
 
43.5
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
1.4
%
 
49.0
%
 
38.9
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
58.1
%
 
6.6
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities
 
5,817

 
Discounted Cash Flows
 
Yield
 
3.4
%
 
52.7
%
 
18.0
%
 
 
 
 
 
 
Projected Collateral Losses
 
1.2
%
 
8.2
%
 
3.8
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
6.6
%
 
19.1
%
 
12.4
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
72.8
%
 
92.1
%
 
83.8
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Corporate debt
 
6,170

 
Discounted Cash Flows
 
Yield
 
16.1
%
 
16.1
%
 
16.1
%
Collateralized loan obligations
 
3,341

 
Discounted Cash Flows
 
Yield
 
12.2
%
 
54.6
%
 
31.6
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
66.8
%
 
74.7
%
 
68.9
%
 
 
 
 
 
 
Projected Collateral Losses
 
18.1
%
 
22.9
%
 
20.2
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
1.2
%
 
11.8
%
 
9.2
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.1
%
 
5.0
%
 
1.7
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
(continued)
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Consumer loans and asset-backed securities backed by consumer loans
 
$
108,671

 
Discounted Cash Flows
 
Yield
 
9.0
%
 
16.0
%
 
10.3
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
50.3
%
 
36.1
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.0
%
 
97.7
%
 
8.1
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
90.9
%
 
55.8
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Performing commercial mortgage loans
 
59,289

 
Discounted Cash Flows
 
Yield
 
8.0
%
 
15.4
%
 
10.9
%
Non-performing commercial mortgage loans and commercial real estate owned
 
30,952

 
Discounted Cash Flows
 
Yield
 
10.2
%
 
25.7
%
 
12.6
%
 
 
 
 
 
 
Months to Resolution
 
6.0

 
15.0

 
10.0

Performing residential mortgage loans
 
129,468

 
Discounted Cash Flows
 
Yield
 
0.4
%
 
42.0
%
 
5.8
%
Non-performing residential mortgage loans and residential real estate owned
 
7,261

 
Discounted Cash Flows
 
Yield
 
2.6
%
 
40.7
%
 
11.2
%
 
 
 
 
 
 
Months to Resolution
 
4.1

 
134.5

 
32.8

Credit default swaps on asset-backed securities
 
4,900

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
19.9
%
 
27.0
%
 
22.6
%
 
 
 
 
 
 
Projected Collateral Losses
 
13.0
%
 
25.7
%
 
22.0
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
5.3
%
 
14.4
%
 
9.2
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
44.8
%
 
54.3
%
 
46.2
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Agency interest only residential mortgage-backed securities
 
3,252

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(1)
 
417

 
1,950

 
839

 
 
 
 
 
 
Projected Collateral Prepayments
 
9.2
%
 
100.0
%
 
68.1
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.0
%
 
7.7
%
 
0.4
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
90.8
%
 
31.5
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded preferred and common equity investment in mortgage-related entity
 
2,500

 
Enterprise Value
 
Equity Multiple(2)
 
1.3x
 
1.3x
 
1.3x
Non-exchange traded preferred equity and debt investment in mortgage-related entity
 
22,500

 
Recent Transactions
 
Transaction Price
 
N/A
 
N/A
 
N/A
Non-controlling equity interest in limited liability company
 
5,591

 
Recent Transactions
 
Transaction Price
 
N/A
 
N/A
 
N/A
Non-controlling equity interest in limited liability company
 
5,966

 
Net Discounted Cash Flows
 
Yield
 
9.1
%
 
9.1
%
 
9.1
%

(1)
Shown in basis points.
(2)
Represent an estimation of where market participants might value an enterprise.
Third-party non-binding valuations are validated by comparing such valuations to internally generated prices based on the Company's models and to recent trading activity in the same or similar instruments.
For those instruments valued using discounted and net discounted cash flows, collateral prepayments, losses, recoveries, and scheduled amortization are projected over the remaining life of the collateral and expressed as a percentage of the collateral's current principal balance. Averages are weighted based on the fair value of the related instrument. In the case of credit default swaps on asset-backed securities, averages are weighted based on each instrument's bond equivalent value. Bond equivalent value represents the investment amount of a corresponding position in the reference obligation, calculated as the difference between the outstanding principal balance of the underlying reference obligation and the fair value, inclusive of accrued interest, of the derivative contract. For those assets valued using the LIBOR Option Adjusted Spread ("OAS") valuation methodology, cash flows are projected using the Company's models over multiple interest rate scenarios, and these projected cash flows are then discounted using the LIBOR rates implied by each interest rate scenario. The LIBOR OAS of an asset is then computed as the unique constant yield spread that, when added to all LIBOR rates in each interest rate scenario generated by the model, will equate (a) the expected present value of the projected asset cash flows over all model scenarios to (b) the actual current market price of the asset. LIBOR OAS is therefore model-dependent. Generally speaking, LIBOR OAS measures the additional yield spread over LIBOR that an asset provides at its current market price after taking into account any interest rate options embedded in the asset. The Company considers the expected timeline to resolution in the determination of fair value for its non-performing commercial and residential loans.
Material changes in any of the inputs above in isolation could result in a significant change to reported fair value measurements. Additionally, fair value measurements are impacted by the interrelationships of these inputs. For example, for instruments subject to prepayments and credit losses, such as non-Agency RMBS and consumer loans and ABS backed by consumer loans, a higher expectation of collateral prepayments will generally be accompanied by a lower expectation of collateral losses. Conversely, higher losses will generally be accompanied by lower prepayments. Because the Company's credit default swaps on asset-backed security holdings represent credit default swap contracts whereby the Company has purchased credit protection, such credit default swaps on asset-backed securities generally have the directionally opposite sensitivity to prepayments, losses, and recoveries as compared to the Company's long securities holdings. Prepayments do not represent a significant input for the Company's commercial mortgage-backed securities and commercial mortgage loans. Losses and recoveries do not represent a significant input for the Company's Agency RMBS interest only securities, given the guarantee of the issuing government agency or government-sponsored enterprise.
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at December 31, 2016:
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
(In thousands)
Cash equivalents
 
$
90,000

 
$

 
$

 
$
90,000

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
868,345

 
$
29,622

 
$
897,967

U.S. Treasury securities
 

 
5,419

 

 
5,419

Private label residential mortgage-backed securities
 

 
53,525

 
90,083

 
143,608

Private label commercial mortgage-backed securities
 

 

 
43,268

 
43,268

Commercial mortgage loans
 

 

 
61,129

 
61,129

Residential mortgage loans
 

 

 
84,290

 
84,290

Collateralized loan obligations
 

 

 
44,956

 
44,956

Consumer loans and asset-backed securities backed by consumer loans(1)
 

 

 
107,157

 
107,157

Corporate debt
 

 
55,091

 
25,004

 
80,095

Real estate owned
 

 

 
3,349

 
3,349

Corporate equity investments(1)
 
4,396

 

 
29,392

 
33,788

Total investments, at fair value
 
4,396

 
982,380

 
518,250

 
1,505,026

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 

 

 
5,326

 
5,326

Credit default swaps on corporate bond indices
 

 
2,744

 

 
2,744

Credit default swaps on corporate bonds
 

 
2,360

 

 
2,360

Credit default swaps on asset-backed indices
 

 
16,713

 

 
16,713

Interest rate swaps
 

 
8,102

 

 
8,102

Total return swaps
 

 

 
155

 
155

Options
 
42

 
2

 

 
44

Futures
 
29

 

 

 
29

Description
 
Level 1
 
Level 2
 
Level 3
 
Total
(continued)
 
(In thousands)
Forwards
 
$

 
$
16

 
$

 
$
16

Warrants
 

 

 
106

 
106

Total financial derivatives–assets, at fair value
 
71

 
29,937

 
5,587

 
35,595

Repurchase agreements
 

 
184,819

 

 
184,819

Total investments and financial derivatives–assets, at fair value and repurchase agreements
 
$
4,467

 
$
1,197,136

 
$
523,837

 
$
1,725,440

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(404,728
)
 
$

 
$
(404,728
)
Government debt
 

 
(132,442
)
 

 
(132,442
)
Corporate debt
 

 
(39,572
)
 

 
(39,572
)
Common stock
 
(8,154
)
 

 

 
(8,154
)
Total investments sold short, at fair value
 
(8,154
)
 
(576,742
)
 

 
(584,896
)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 

 
(2,840
)
 

 
(2,840
)
Credit default swaps on corporate bonds
 

 
(6,654
)
 

 
(6,654
)
Credit default swaps on asset-backed indices
 

 
(2,899
)
 

 
(2,899
)
Credit default swaps on asset-backed securities
 

 

 
(256
)
 
(256
)
Interest rate swaps
 

 
(5,162
)
 

 
(5,162
)
Total return swaps
 

 
(55
)
 
(249
)
 
(304
)
Futures
 
(69
)
 

 

 
(69
)
Forwards
 

 
(472
)
 

 
(472
)
Mortgage loan purchase commitments
 

 
(31
)
 

 
(31
)
Total financial derivatives–liabilities, at fair value
 
(69
)
 
(18,113
)
 
(505
)
 
(18,687
)
Total investments sold short, and financial derivatives–liabilities, at fair value
 
$
(8,223
)
 
$
(594,855
)
 
$
(505
)
 
$
(603,583
)

(1)
Conformed to current period presentation.

The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2016:
 
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities
 
$
47,024

 
Market Quotes
 
Non Binding Third-Party Valuation
 
$
2.00

 
$
101.02

 
$
67.51

Collateralized loan obligations
 
37,517

 
Market Quotes
 
Non Binding Third-Party Valuation
 
9.42

 
100.25

 
83.36

Corporate debt and non-exchange traded corporate equity
 
19,017

 
Market Quotes
 
Non Binding Third-Party Valuation
 
1.88

 
102.25

 
87.14

Private label commercial mortgage-backed securities
 
27,283

 
Market Quotes
 
Non Binding Third-Party Valuation
 
5.17

 
77.75

 
40.88

Agency interest only residential mortgage-backed securities
 
23,322

 
Market Quotes
 
Non Binding Third-Party Valuation
 
2.47

 
20.17

 
11.65

Total return swaps
 
(94
)
 
Market Quotes
 
Non Binding Third-Party Valuation (1)
 
98.25

 
99.50

 
98.77

Private label residential mortgage-backed securities
 
43,059

 
Discounted Cash Flows
 
Yield
 
0.6
%
 
20.5
%
 
11.0
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
81.0
%
 
10.0
%
 
 
 
 
 
 
Projected Collateral Losses
 
1.4
%
 
51.2
%
 
41.4
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
0.4
%
 
53.6
%
 
41.2
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
90.7
%
 
7.4
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities
 
15,985

 
Discounted Cash Flows
 
Yield
 
8.8
%
 
57.0
%
 
23.6
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.1
%
 
5.3
%
 
2.2
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
0.9
%
 
20.5
%
 
10.7
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
77.8
%
 
99.0
%
 
87.1
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Corporate debt and warrants
 
10,080

 
Discounted Cash Flows
 
Yield
 
19.7
%
 
19.7
%
 
19.7
%
Collateralized loan obligations
 
7,439

 
Discounted Cash Flows
 
Yield
 
11.2
%
 
50.3
%
 
20.5
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
11.4
%
 
55.2
%
 
45.5
%
 
 
 
 
 
 
Projected Collateral Losses
 
4.5
%
 
28.3
%
 
10.7
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
1.5
%
 
27.2
%
 
8.6
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
29.8
%
 
51.5
%
 
35.2
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Consumer loans and asset-backed securities backed by consumer loans(2)
 
107,157

 
Discounted Cash Flows
 
Yield
 
9.0
%
 
25.0
%
 
11.0
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
45.4
%
 
25.6
%
 
 
 
 
 
 
Projected Collateral Losses
 
3.3
%
 
97.4
%
 
9.4
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
87.7
%
 
65.0
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Performing commercial mortgage loans
 
32,557

 
Discounted Cash Flows
 
Yield
 
8.0
%
 
17.2
%
 
11.6
%
 
 
 
 
 
 
 
 
 
 
 
 
 
(continued)
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Non-performing commercial mortgage loans and commercial real estate owned
 
$
30,222

 
Discounted Cash Flows
 
Yield
 
10.2
%
 
27.8
%
 
16.3
%
 
 
 
 
 
 
Months to Resolution
 
3.0

 
39.1

 
19.5

Performing residential mortgage loans
 
78,576

 
Discounted Cash Flows
 
Yield
 
5.0
%
 
13.5
%
 
6.6
%
Non-performing residential mortgage loans and residential real estate owned
 
7,413

 
Discounted Cash Flows
 
Yield
 
5.8
%
 
39.9
%
 
9.7
%
 
 
 
 
 
 
Months to Resolution
 
1.8

 
162.9

 
41.9

Credit default swaps on asset-backed securities
 
5,070

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
19.3
%
 
29.8
%
 
22.7
%
 
 
 
 
 
 
Projected Collateral Losses
 
15.3
%
 
27.6
%
 
22.2
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
4.7
%
 
15.3
%
 
8.7
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
43.2
%
 
50.2
%
 
46.4
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded equity investments in commercial mortgage-related private partnerships
 
3,090

 
Discounted Cash Flows
 
Yield
 
16.5
%
 
16.5
%
 
16.5
%
 
 
 
 
 
 
Expected Holding Period (Months)
 
2.9

 
2.9

 
2.9

Agency interest only residential mortgage-backed securities
 
6,300

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(3)
 
142

 
2,831

 
568

 
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
100.0
%
 
62.6
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.0
%
 
15.7
%
 
1.0
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
88.1
%
 
36.4
%
 
 


 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded preferred and common equity investment in mortgage-related entity
 
2,500

 
Enterprise Value
 
Equity Multiple(4)
 
1.3x

 
1.3x

 
1.3x

Non-controlling equity interest in limited liability company(2)
 
7,315

 
Net Discounted Cash Flows
 
Yield
 
8.5
%
 
8.5
%
 
8.5
%
Non-exchange traded preferred equity investment in mortgage-related entity
 
12,500

 
Recent Transactions
 
Transaction Price
 
N/A

 
N/A

 
N/A

(1)
Represents valuations on underlying assets.
(2)
Conformed to current period presentation.
(3)
Shown in basis points.
(4)
Represent an estimation of where market participants might value an enterprise.
Third-party non-binding valuations are validated by comparing such valuations to internally generated prices based on the Company's models and to recent trading activity in the same or similar instruments.
For those instruments valued using discounted and net discounted cash flows, collateral prepayments, losses, recoveries, and scheduled amortization are projected over the remaining life of the collateral and expressed as a percentage of the collateral's current principal balance. Averages are weighted based on the fair value of the related instrument. In the case of credit default swaps on asset-backed securities, averages are weighted based on each instrument's bond equivalent value. Bond equivalent value represents the investment amount of a corresponding position in the reference obligation, calculated as the difference between the outstanding principal balance of the underlying reference obligation and the fair value, inclusive of accrued interest, of the derivative contract. For those assets valued using the LIBOR Option Adjusted Spread valuation methodology, cash flows are projected using the Company's models over multiple interest rate scenarios, and these projected cash flows are then discounted using the LIBOR rates implied by each interest rate scenario. The LIBOR OAS of an asset is then computed as the unique constant yield spread that, when added to all LIBOR rates in each interest rate scenario generated by the model, will equate (a) the expected present value of the projected asset cash flows over all model scenarios to (b) the actual current market price of the asset. LIBOR OAS is therefore model-dependent. Generally speaking, LIBOR OAS measures the additional yield spread over LIBOR that an asset provides at its current market price after taking into account any interest rate options embedded in the asset.
Material changes in any of the inputs above in isolation could result in a significant change to reported fair value measurements. Additionally, fair value measurements are impacted by the interrelationships of these inputs. For example, a higher expectation of collateral prepayments will generally be accompanied by a lower expectation of collateral losses. Conversely, higher losses will generally be accompanied by lower prepayments. Because the Company's credit default swaps on asset-backed security holdings represent credit default swap contracts whereby the Company has purchased credit protection, such default swaps on asset-backed securities generally have the directionally opposite sensitivity to prepayments, losses, and recoveries as compared to the Company's long securities holdings. Prepayments do not represent a significant input for the Company's commercial mortgage-backed securities and commercial mortgage loans. Losses and recoveries do not represent a significant input for the Company's Agency RMBS interest only securities, given the guarantee of the issuing government agency or government-sponsored enterprise.
The tables below include a roll-forward of the Company's financial instruments for the three and six month periods ended June 30, 2017 and 2016 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy.
Level 3—Fair Value Measurement Using Significant Unobservable Inputs:
Three Month Period Ended June 30, 2017
(In thousands)
Ending
Balance as of 
March 31, 2017
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
June 30, 2017
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
29,425

 
$
(2,320
)
 
$
(402
)
 
$
(163
)
 
$
(417
)
 
$
(126
)
 
$

 
$
(21,101
)
 
$
4,896

Private label residential mortgage-backed securities
80,332

 
(476
)
 
1,137

 
3,327

 
27,972

 
(9,733
)
 
16,089

 
(39,525
)
 
79,123

Private label commercial mortgage-backed securities
41,300

 
276

 
(3,338
)
 
4,991

 
20

 
(16,734
)
 

 
(12,706
)
 
13,809

Commercial mortgage loans
62,508

 
101

 
79

 
(56
)
 
4,500

 
(1,236
)
 

 

 
65,896

Residential mortgage loans
112,650

 
537

 
1,133

 
(481
)
 
37,048

 
(14,790
)
 

 

 
136,097

Collateralized loan obligations
70,561

 
(4,849
)
 
532

 
479

 
18,157

 
(23,233
)
 

 
(19,111
)
 
42,536

Consumer loans and asset-backed securities backed by consumer loans(1)
107,842

 
(3,208
)
 
478

 
(555
)
 
25,594

 
(21,480
)
 

 

 
108,671

Corporate debt
59,609

 
154

 
216

 
29

 
36,397

 
(75,870
)
 

 

 
20,535

Real estate owned
25,390

 

 
365

 
(401
)
 
54

 
(431
)
 

 

 
24,977

Corporate equity investments(1)
33,917

 

 
1,519

 
(994
)
 
6,775

 
(5,519
)
 

 

 
35,698

Total investments, at fair value
623,534

 
(9,785
)
 
1,719

 
6,176

 
156,100

 
(169,152
)
 
16,089

 
(92,443
)
 
532,238

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
5,828

 

 
331

 
(721
)
 
10

 
(341
)
 

 

 
5,107

Total return swaps

 

 
65

 

 

 
(65
)
 

 

 

Total financial derivatives– assets, at fair value
5,828

 

 
396

 
(721
)
 
10

 
(406
)
 

 

 
5,107

Total investments and financial derivatives–assets, at fair value
$
629,362

 
$
(9,785
)
 
$
2,115

 
$
5,455

 
$
156,110

 
$
(169,558
)
 
$
16,089

 
$
(92,443
)
 
$
537,345

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
Ending
Balance as of 
March 31, 2017
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
June 30, 2017
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(218
)
 
$

 
$
(19
)
 
$
12

 
$
446

 
$
(428
)
 
$

 
$

 
$
(207
)
Total return swaps

 

 
(85
)
 

 
21

 
64

 

 

 

Total financial derivatives– liabilities, at fair value
(218
)
 

 
(104
)
 
12

 
467

 
(364
)
 

 

 
(207
)
(1)
Conformed to current period presentation.
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at June 30, 2017, as well as Level 3 financial instruments disposed of by the Company during the three month period ended June 30, 2017. For Level 3 financial instruments held by the Company at June 30, 2017, change in net unrealized gain (loss) of $5.1 million, $(0.7) million, and $0.01 million for the three month period ended June 30, 2017 relate to investments, financial derivatives–assets, and financial derivatives–liabilities, respectively.
As of June 30, 2017, the Company modified its procedures to determine the level within the hierarchy for certain financial instruments. Under the revised procedure, the Company examines financial instruments individually rather than in cohorts of like instruments as it had previously. As of June 30, 2017, the Company transferred $92.4 million of securities from Level 3 to Level 2 and $16.1 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from multiple third-party pricing sources.
Three Month Period Ended June 30, 2016
(In thousands)
Ending
Balance as of 
March 31, 2016
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
June 30, 2016
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
22,306

 
$
(1,888
)
 
$
(82
)
 
$
(133
)
 
$
303

 
$

 
$

 
$

 
$
20,506

Private label residential mortgage-backed securities
113,382

 
1,109

 
(290
)
 
(1,310
)
 
1,687

 
(6,100
)
 
12,823

 
(8,790
)
 
112,511

Private label commercial mortgage-backed securities
35,350

 
431

 

 
(839
)
 

 

 

 

 
34,942

Commercial mortgage loans
56,365

 
727

 
(1
)
 
(671
)
 

 
(6,954
)
 

 

 
49,466

Residential mortgage loans
35,580

 
141

 
757

 
(147
)
 
17,101

 
(6,783
)
 

 

 
46,649

Collateralized loan obligations
34,415

 
(1,942
)
 
(279
)
 
145

 
1,178

 
(408
)
 

 

 
33,109

Consumer loans and asset-backed securities backed by consumer loans
143,854

 
(2,713
)
 
6

 
(655
)
 
37,046

 
(23,143
)
 

 

 
154,395

Corporate debt
24,552

 
(160
)
 
275

 
1,874

 
49,353

 
(38,920
)
 

 

 
36,974

Real estate owned
21,843

 

 
1,978

 
(1,750
)
 
884

 
(18,793
)
 

 

 
4,162

Private corporate equity investments
24,599

 

 
101

 
697

 
2,590

 
(8,569
)
 

 

 
19,418

Total investments, at fair value
512,246

 
(4,295
)
 
2,465

 
(2,789
)
 
110,142

 
(109,670
)
 
12,823

 
(8,790
)
 
512,132

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
Ending
Balance as of 
March 31, 2016
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
June 30, 2016
Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
6,227

 

 
373

 
(149
)
 
(24
)
 
(359
)
 

 

 
6,068

Total return swaps
1,074

 

 
3,412

 
(250
)
 
(3,146
)
 
(266
)
 

 

 
824

Warrants
100

 

 

 

 

 

 

 

 
100

Total financial derivatives– assets, at fair value
7,401

 

 
3,785

 
(399
)
 
(3,170
)
 
(625
)
 

 

 
6,992

Total investments and financial derivatives–assets, at fair value
$
519,647

 
$
(4,295
)
 
$
6,250

 
$
(3,188
)
 
$
106,972

 
$
(110,295
)
 
$
12,823

 
$
(8,790
)
 
$
519,124

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments sold short, at fair value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
$
(3,029
)
 
$
(9
)
 
$
171

 
$
(309
)
 
$
10,368

 
$
(17,139
)
 
$

 
$

 
$
(9,947
)
Total investments sold short, at fair value
(3,029
)
 
(9
)
 
171

 
(309
)
 
10,368

 
(17,139
)
 

 

 
(9,947
)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(220
)
 
$

 
$
(63
)
 
$
24

 
$

 
$
25

 
$

 
$

 
$
(234
)
Total return swaps
(675
)
 

 
(2,115
)
 
(342
)
 
2,348

 
(232
)
 

 

 
(1,016
)
Total financial derivatives– liabilities, at fair value
(895
)
 

 
(2,178
)
 
(318
)
 
2,348

 
(207
)
 

 

 
(1,250
)
Guarantees:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Guarantees
(616
)
 

 

 
304

 

 

 

 

 
(312
)
Total guarantees
(616
)
 

 

 
304

 

 

 

 

 
(312
)
Total investments sold short, financial derivatives– liabilities, and guarantees, at fair value
$
(4,540
)
 
$
(9
)
 
$
(2,007
)
 
$
(323
)
 
$
12,716

 
$
(17,346
)
 
$

 
$

 
$
(11,509
)
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at June 30, 2016, as well as Level 3 financial instruments disposed of by the Company during the three month period ended June 30, 2016. For Level 3 financial instruments held by the Company at June 30, 2016, change in net unrealized gain (loss) of $(2.2) million, $(0.03) million, $0.3 million, $(0.6) million, and $0.3 million, for the three month period ended June 30, 2016 relate to investments, investments sold short, financial derivatives–assets, financial derivatives–liabilities, and guarantees, respectively.
As of June 30, 2016, the Company transferred $8.8 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and similar assets. This increase in observed trading activity has led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view.
In addition, as of June 30, 2016, the Company transferred $12.8 million of non-Agency RMBS from Level 2 to Level 3. Since March 31, 2016, these securities have exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities.
Six Month Period Ended June 30, 2017
(In thousands)
Ending
Balance as of 
December 31, 2016
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
June 30, 2017
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
29,622

 
$
(4,913
)
 
$
(437
)
 
$
65

 
$
1,785

 
$
(125
)
 
$

 
$
(21,101
)
 
$
4,896

Private label residential mortgage-backed securities
90,083

 
1,036

 
434

 
6,034

 
26,800

 
(29,349
)
 
11,348

 
(27,263
)
 
79,123

Private label commercial mortgage-backed securities
43,268

 
632

 
(2,996
)
 
6,402

 
20

 
(20,811
)
 

 
(12,706
)
 
13,809

Commercial mortgage loans
61,129

 
631

 
416

 
1,150

 
27,545

 
(24,975
)
 

 

 
65,896

Residential mortgage loans
84,290

 
678

 
1,081

 
(77
)
 
71,186

 
(21,061
)
 

 

 
136,097

Collateralized loan obligations
44,956

 
(6,032
)
 
1,453

 
3,011

 
56,869

 
(38,609
)
 

 
(19,112
)
 
42,536

Consumer loans and asset-backed securities backed by consumer loans(1)
107,157

 
(6,264
)
 
(74
)
 
281

 
50,012

 
(42,441
)
 

 

 
108,671

Corporate debt
25,004

 
253

 
548

 
187

 
83,492

 
(88,949
)
 

 

 
20,535

Real estate owned
3,349

 

 
424

 
(295
)
 
24,211

 
(2,712
)
 

 

 
24,977

Corporate equity investments(1)
29,392

 

 
1,519

 
(723
)
 
11,775

 
(6,265
)
 

 

 
35,698

Total investments, at fair value
518,250

 
(13,979
)
 
2,368

 
16,035

 
353,695

 
(275,297
)
 
11,348

 
(80,182
)
 
532,238

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
5,326

 

 
368

 
(218
)
 
68

 
(437
)
 

 

 
5,107

Total return swaps
155

 

 
222

 
(155
)
 

 
(222
)
 

 

 

Warrants
106

 

 
(100
)
 
(6
)
 

 

 

 

 

Total financial derivatives– assets, at fair value
5,587

 

 
490

 
(379
)
 
68

 
(659
)
 

 

 
5,107

Total investments and financial derivatives–assets, at fair value
$
523,837

 
$
(13,979
)
 
$
2,858

 
$
15,656

 
$
353,763

 
$
(275,956
)
 
$
11,348

 
$
(80,182
)
 
$
537,345

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(256
)
 
$

 
$
(465
)
 
$
477

 
$
465

 
$
(428
)
 
$

 
$

 
$
(207
)
Total return swaps
(249
)
 

 
(292
)
 
250

 
304

 
(13
)
 

 

 

Total financial derivatives– liabilities, at fair value
(505
)
 

 
(757
)
 
727

 
769

 
(441
)
 

 

 
(207
)
(1)
Conformed to current period presentation.
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at June 30, 2017, as well as Level 3 financial instruments disposed of by the Company during the six month period ended June 30, 2017. For Level 3 financial instruments held by the Company at June 30, 2017, change in net unrealized gain (loss) of $9.0 million, $(0.2) million, and $0.05 million for the six month period ended June 30, 2017 relate to investments, financial derivatives–assets, and financial derivatives–liabilities, respectively.
As of June 30, 2017, the Company modified certain of its procedures to determine the level within the hierarchy for certain financial instruments. Under the revised procedure, the Company examines financial instruments individually rather than in cohorts of like instruments as it had previously. As of June 30, 2017, the Company transferred $80.2 million of securities from Level 3 to Level 2 and $11.3 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from multiple third-party pricing sources.
Six Month Period Ended June 30, 2016
(In thousands)
Ending
Balance as of December 31, 2015
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in
Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
June 30, 2016
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
24,918

 
$
(3,945
)
 
$
(90
)
 
$
(679
)
 
$
302

 
$

 
$

 
$

 
$
20,506

Private label residential mortgage-backed securities
116,435

 
1,517

 
(283
)
 
(2,370
)
 
7,419

 
(12,461
)
 
11,261

 
(9,007
)
 
112,511

Private label commercial mortgage-backed securities
34,145

 
886

 
322

 
(3,840
)
 
7,844

 
(4,415
)
 

 

 
34,942

Commercial mortgage loans
66,399

 
1,272

 
182

 
223

 
13,424

 
(32,034
)
 

 

 
49,466

Residential mortgage loans
22,089

 
248

 
865

 
127

 
32,066

 
(8,746
)
 

 

 
46,649

Collateralized loan obligations
45,974

 
(2,869
)
 
801

 
417

 
1,178

 
(12,392
)
 

 

 
33,109

Consumer loans and asset-backed securities backed by consumer loans
115,376

 
(5,596
)
 
6

 
(549
)
 
88,956

 
(43,798
)
 

 

 
154,395

Corporate debt
27,028

 
(46
)
 
255

 
(2,102
)
 
52,320

 
(40,481
)
 

 

 
36,974

Real estate owned
12,522

 

 
2,238

 
(331
)
 
10,672

 
(20,939
)
 

 

 
4,162

Private corporate equity investments
22,088

 

 
(29
)
 
(531
)
 
6,517

 
(8,627
)
 

 

 
19,418

Total investments, at fair value
486,974

 
(8,533
)
 
4,267

 
(9,635
)
 
220,698

 
(183,893
)
 
11,261

 
(9,007
)
 
512,132

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
6,332

 
$

 
$
464

 
$
(255
)
 
$
12

 
$
(485
)
 
$

 
$

 
$
6,068

Total return swaps
85

 

 
(103
)
 
739

 
423

 
(320
)
 

 

 
824

Warrants
150

 

 
(50
)
 

 

 

 

 

 
100

Total financial derivatives– assets, at fair value
6,567

 

 
311

 
484

 
435

 
(805
)
 

 

 
6,992

Total investments and financial derivatives–assets, at fair value
$
493,541

 
$
(8,533
)
 
$
4,578

 
$
(9,151
)
 
$
221,133

 
$
(184,698
)
 
$
11,261

 
$
(9,007
)
 
$
519,124

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments sold short, at fair value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
$
(448
)
 
$
(8
)
 
$
531

 
$
(558
)
 
$
11,255

 
$
(20,719
)
 
$

 
$

 
$
(9,947
)
Total investments sold short, at fair value
(448
)
 
(8
)
 
531

 
(558
)
 
11,255

 
(20,719
)
 

 

 
(9,947
)
Financial derivatives– liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(221
)
 
$

 
$
(79
)
 
$
24

 
$

 
$
42

 
$

 
$

 
$
(234
)
Total return swaps
(4,662
)
 

 
(4,365
)
 
3,646

 
4,686

 
(321
)
 

 

 
(1,016
)
Total financial derivatives– liabilities, at fair value
(4,883
)
 

 
(4,444
)
 
3,670

 
4,686

 
(279
)
 

 

 
(1,250
)
Guarantees:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Guarantees
(828
)
 

 

 
516

 

 

 

 

 
(312
)
Total guarantees
(828
)
 

 

 
516

 

 

 

 

 
(312
)
Total financial derivatives– liabilities and guarantees, at fair value
$
(6,159
)
 
$
(8
)
 
$
(3,913
)
 
$
3,628

 
$
15,941

 
$
(20,998
)
 
$

 
$

 
$
(11,509
)

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at June 30, 2016, as well as Level 3 financial instruments disposed of by the Company during the six month period ended June 30, 2016. For Level 3 financial instruments held by the Company at June 30, 2016, change in net unrealized gain (loss) of $(10.9) million, $(0.04) million, $0.9 million, $(0.1) million, and $0.5 million, for the six month period ended June 30, 2016 relate to investments, investments sold short, financial derivatives–assets, financial derivatives–liabilities, and guarantees, respectively.
As of June 30, 2016, the Company transferred $9.0 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and similar assets. This increase in observed trading activity has led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view.
In addition, as of June 30, 2016, the Company transferred $11.3 million of non-Agency RMBS from Level 2 to Level 3. Since December 31, 2015, these securities have exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities.
There were no transfers of financial instruments between Level 1 and Level 2 during the three or six month periods ended June 30, 2017 and 2016.